Painazol Shingles Symptom Relief Cream (Ionx Holdings d/b/a HelloLife Inc.)
Welcome to the PulseAid listing for the Painazol Shingles Symptom Relief Cream drug offered from Ionx Holdings d/b/a HelloLife Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ionx Holdings d/b/a HelloLife Inc. |
| NON-PROPRIETARY NAME: | Cedron, Mezereum, Phytolacca, Sempervivum, Croton, Mentha pip, Rhus tox, Dulcamara, Ranunc bulb, Grindelia, Salicylicum ac |
| SUBSTANCE NAME: | SIMABA CEDRON SEED; DAPHNE MEZEREUM BARK; PHYTOLACCA AMERICANA ROOT; SEMPERVIVUM TECTORUM LEAF; CROTON TIGLIUM SEED; MENTHA PIPERITA; TOXICODENDRON PUBESCENS LEAF; SOLANUM DULCAMARA TOP; RANUNCULUS BU |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2013-08-05 |
| END MARKETING DATE: | 0000-00-00 |
Painazol Shingles Symptom Relief Cream HUMAN OTC DRUG Details:
| Item Description | Painazol Shingles Symptom Relief Cream from Ionx Holdings d/b/a HelloLife Inc. |
| LABELER NAME: | Ionx Holdings d/b/a HelloLife Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3; 1; 1; 2; 3; 1; 3; 2; 3; 1; 3([hp_C]/128g; [hp_X]/128g; [hp_X]/128g; [hp_X]/128g; [hp_X]/128g; [hp_X]/128g; [hp_X]/128g; [hp_X]/128g; [hp_X]/128g; [hp_X]/128g; [hp_X]/128g) |
| START MARKETING DATE: | 2013-08-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49726-033_065f538f-92c6-4f30-b1cb-1597e8a4eaa0 |
| PRODUCT NDC: | 49726-033 |
| APPLICATION NUMBER: | |
Other SIMABA CEDRON SEED; DAPHNE MEZEREUM BARK; PHYTOLACCA AMERICANA ROOT; SEMPERVIVUM TECTORUM LEAF; CROTON TIGLIUM SEED; MENTHA PIPERITA; TOXICODENDRON PUBESCENS LEAF; SOLANUM DULCAMARA TOP; RANUNCULUS BU Pharmaceutical Manufacturers / Labelers:
